121
Participants
Start Date
March 31, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
September 30, 2009
BMS-582949
Tablets, Oral, 300 mg, once daily, 12 weeks
Placebo
Tablets, Oral, placebo, once daily, 12 weeks
Local Institution, Taoyuan District
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, Culiacán
Local Institution, Mexico City
Local Institution, Santiago de C.
The Arthritis Group, Philadelphia
Local Institution, Madrid
Local Institution, Bordeaux
Local Institution, Chambray-lès-Tours
Arthritis Clinic, Jackson
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Vizcaya
Local Institution, Nuevo León
Health Research Of Oklahoma, Oklahoma City
Local Institution, Paris
Walter F Chase Md, Austin
G. Timothy Kelly, Md, Las Vegas
Orrin M. Troum,M D, Santa Monica
Desert Medical Advances, Palm Desert
Tacoma Center For Arthritis Research Ps, Tacoma
Local Institution, Ciudad Autonoma de Buenos Aire
Local Institution, České Budějovice
Local Institution, Hradec Králové
Local Institution, Prague
Local Institution, Cheonan
Local Institution, Taichung
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY